Omega Therapeutics Inc Stock Ownership - Who owns Omega Therapeutics?

Insider buying vs selling

Have Omega Therapeutics Inc insiders been buying or selling?
Richard A. YoungDirector2023-06-025,000$8.00
Richard A. YoungDirector2023-05-015,000$8.00
Richard A. YoungDirector2023-04-065,000$8.00
Richard A. YoungDirector2023-03-1710,000$8.00
Flagship Pioneering Inc10% Owner2023-02-271,329,324$5.78
Flagship Pioneering Inc10% Owner2023-02-271,993,986$5.78
Richard A. YoungDirector2023-01-1020,000$8.00

1 of 1

OMGA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OMGA insiders and whales buy or sell their stock.

OMGA Shareholders

What type of owners hold Omega Therapeutics Inc stock?
Flagship Pioneering Inc56.99%31,422,638$58.76MInsider
Flagship Pioneering Inc53.00%29,225,579$54.65MInstitution
Fmr LLC9.42%5,194,102$9.71MInstitution
Harbourvest Partners LLC6.37%3,512,110$6.57MInstitution
Artal Group Sa4.59%2,533,045$4.74MInstitution
Invus Public Equities LP4.12%2,273,530$4.25MInsider
State Of Wisconsin Investment Board3.37%1,857,265$3.47MInstitution
Blackrock Inc2.77%1,529,939$2.86MInstitution
Vanguard Group Inc2.69%1,485,635$2.78MInstitution
Flagship Pioneering Fund Vii General Partner LLC2.41%1,329,324$2.49MInsider

1 of 3

OMGA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OMGA58.06%41.94%Net Buying
VTGN9.82%90.18%Net Buying
RANI6.42%51.75%Net BuyingNet Buying
ADAP8.18%91.82%Net SellingNet Selling

Omega Therapeutics Stock Ownership FAQ

Who owns Omega Therapeutics?

Omega Therapeutics (NASDAQ: OMGA) is owned by 92.29% institutional shareholders, 66.65% Omega Therapeutics insiders, and 0.00% retail investors. Flagship Pioneering Inc is the largest individual Omega Therapeutics shareholder, owning 31.42M shares representing 56.99% of the company. Flagship Pioneering Inc's Omega Therapeutics shares are currently valued at $57.19M.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.